SNAP Biosciences is developing a universal immune receptor platform, SNAP-CAR, that enables engineered T and NK cells to be directed by already existing antibody-based therapeutics.
Highlighting Emerging Oncology
Our profiles are designed to serve as a credible, public-facing version of your company story – highly valuable for potential partners, investors, scientific collaborators, and future hires.
Featured emerging biotech
Get Your Company Profiled on Oncoleader!
A founder-friendly company profile that tells your story with scientific clarity and professional polish.
Included in Basic Profile ($3000):
- Oncoleader-style video (3-6 minutes)
- Full company writeup (Company Overview, Technology Breakdown & Real-World Impact)
- Professionally structured “Company Snapshot”
- Key leadership bios
- Link to relevant publications
Premium Add-Ons:
Founder Spotlight Videos
Founder Spotlight Videos
This is a short, stylized interview-style video showcasing your story and leadership (3–5 mins + 60 sec teaser). Ideal for LinkedIn, events, or pitch decks.
These personable videos will transform your company from a logo and a concept into a leader on a mission.
Investor-Friendly PDF 1-Pager
Investor-Friendly PDF 1-Pager
A clean, company-branded, professional summary PDF version of your profile. These are perfect for investor outreach or conference booths.
Pitch Deck & Messaging Tune-Up
Pitch Deck & Messaging Tune-Up
Our analysts will take a look at your IR material, and align your messaging with what investors actually want to see.
This includes:
- Optimizing deck organization and focus
- Rewriting key slides for clarity and punch
- Suggestions for improving figures or visuals
- Coaching on how to deliver core concepts so that your message hits as hard as possible
Company Profile Application Form
Submit your form and we will get the process started. Typical response time is: <12 hours. Price of add-ons is added to price of Basic Profile.
Why get profiled?
At Oncoleader, we don’t just summarize your work, we craft a strategic, science-grounded story that highlights your company’s unique therapeutic approach, showcases your long-term vision, and positions you as a serious innovator in oncology.
Here’s what you get when you’re profiled:
Clear, Compelling Narrative
We dig into your biology, your platform, and your strategy, and help you tell the story the way it deserves to be told. Your profile will focus on what makes you different, why your tech matters, and where you're headed.
Premium Content That Stands Out
Each profile comes with a suite of high-quality visuals - including explainer videos, mechanism-of-action figures, technology diagrams, and market insights. No fluff, no corporate jargon. Just clarity, polish, and punch.
Multi-Channel Visibility
Your profile will be featured on our in our weekly industry newsletter and on our LinkedIn channel (15k+ biotech followers) to get you in front of the people who actually care about what you’re building.
Latest Emerging Biotech
Check out these profiles that were recently added to our library.
Encelta AG is a swiss-based biotech developing a universal TCR-T cell platform designed to augment CD3-targeting T cell engagers.
Jabez Biosciences is a US-Based biotech developing a potential best-in-class small molecule inhibitor of DHODH that they’re using to augment existing pipelines.
Oncoleader's Impact
We’ve helped biotech executives sharpen their message and get the attention they deserve. Here’s how they describe the impact of their Oncoleader profile.
